The_DT question_NN being_VBG asked_VBD wheather_NN successful_JJ people_NNS should_MD try_VB new_JJ things_NNS and_CC take_VB risks_NNS or_CC they_PRP should_MD keep_VB on_IN doing_VBG what_WP they_PRP already_RB know_VB and_CC what_WP they_PRP already_RB do_VBP ._.
This_DT is_VBZ an_DT interesting_JJ topic_NN since_IN it_PRP is_VBZ related_VBN with_IN risk-taking_JJ by_IN the_DT people_NNS ._.
In_IN my_PRP$ opinion_NN ,_, i_FW believe_VBP that_IN people_NNS should_MD try_VB new_JJ things_NNS and_CC try_VB to_TO take_VB risks_NNS if_IN they_PRP can_MD ._.
I_PRP think_VBP ,_, If_IN we_PRP do_VBP some_DT thing_NN for_IN a_DT long_JJ time_NN than_IN we_PRP would_MD already_RB improve_VB that_IN skills_NNS and_CC we_PRP would_MD get_VB bore_VBN of_IN doing_VBG one_CD thing_NN again_RB and_CC again_RB ._.
And_CC being_VBG a_DT successful_JJ person_NN there_RB would_MD be_VB less_RBR chances_NNS of_IN loss_NN ._.
Or_CC if_IN there_EX might_MD any_DT loss_NN occured_VBD than_IN it_PRP will_MD not_RB affect_VB that_IN person_NN business_NN much_RB more_RBR ._.
And_CC ,_, if_IN we_PRP would_MD do_VB some_DT different_JJ things_NNS it_PRP can_MD be_VB good_JJ as_IN far_RB as_IN change_NN is_VBZ concerned_VBN ._.
If_IN we_PRP have_VBP capability_NN to_TO take_VB risks_NNS and_CC to_TO improve_VB ourself_NN than_IN there_EX is_VBZ nothing_NN wrong_JJ in_IN taking_VBG risks_NNS ._.
I_PRP am_VBP a_DT pharmacist_NN ,_, So_IN being_VBG a_DT pharmacist_NN i_FW believe_VB in_IN research_NN and_CC development_NN ._.
And_CC in_IN research_NN and_CC development_NN i_FW try_VB to_TO innovate_VB more_JJR and_CC more_RBR useful_JJ drugs_NNS which_WDT have_VBP low_JJ side_JJ effects_NNS and_CC have_VBP high_JJ margin_NN of_IN safety_NN ._.
And_CC for_IN that_DT purpose_NN i_FW believe_VB in_IN taking_VBG risk_NN in_IN changing_VBG already_RB existing_VBG formula_NN of_IN any_DT perticular_JJ formulation_NN or_CC drug_NN ._.
Which_WDT can_MD help_VB me_PRP to_TO invent_VB new_JJ drug_NN which_WDT is_VBZ more_RBR advantageous_JJ than_IN the_DT existing_VBG drug_NN ._.
So_RB ,_, according_VBG to_TO me_PRP ,_, we_PRP should_MD keep_VB on_IN trying_VBG to_TO do_VB new_JJ thing_NN apart_RB from_IN what_WP we_PRP do_VBP in_IN our_PRP$ day_NN to_TO day_NN curriculum_NN ._.
Furthermore_RB ,_, i_FW thing_NN ,_, during_IN present_JJ time_NN where_WRB each_DT and_CC every_DT person_NN try_VB to_TO gain_VB more_JJR and_CC more_JJR knowledge_NN as_IN compared_VBN to_TO others_NNS ._.
And_CC for_IN this_DT everyone_NN has_VBZ to_TO take_VB more_JJR chances_NNS to_TO improve_VB his_PRP$ skills_NNS and_CC to_TO become_VB better_JJR than_IN others_NNS ._.
For_IN example_NN ,_, if_IN some_DT one_CD would_MD not_RB have_VB taken_VBN risk_NN of_IN developing_VBG Atomic_JJ bomb_NN than_IN we_PRP would_MD not_RB have_VB been_VBN aware_JJ of_IN that_DT ._.
In_IN conclusion_NN ,_, i_FW have_VBP shown_VBN that_IN successful_JJ person_NN should_MD try_VB new_JJ things_NNS and_CC take_VB risks_NNS ._.
Since_IN without_IN risks_NNS ,_, there_EX will_MD not_RB be_VB any_DT development_NN ._.
